Zyla Life Sciences SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Zyla Life Sciences had SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount of $43.19 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesBalance · last filed 2020-05-14
- 2020-03-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $43.19M.
- 2019-12-31: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $39.70M.
- 2019-09-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $44.98M.
- 2019-06-30: SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount $43.57M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount |
|---|---|
| 2020-03-31 | $43.19M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $39.70M 10-Q · filed 2020-05-14 |
| 2019-09-30 | $44.98M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $43.57M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $52.21M 10-Q · filed 2020-05-14 |
| 2019-01-31 | $33.40M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $18.47M 10-Q · filed 2020-05-14 |
| 2018-09-30 | $17.29M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $16.62M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $16.16M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $4.82M 10-K · filed 2020-03-26 |